Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05757609

Transcranial Stimulation for Physiotherapy Optimisation - Chronic Low Back Pain (STOP-CLBP)

The main objective of this study is to investigate the effects of non-invasive brain stimulation (the so-called transcranial direct current stimulation ; tDCS) combined with an active physiotherapy program on the multidimensional impact of pain in patients with Chronic Low Back Pain (CLBP).

The secondary objectives are to compare the effects of these interventions on fear of movement, psycho-emotional state, function, functional connectivity of the left dorsolaterla prefrontal cortex (DLPFC) and erector spinae activity.

Participants will perform:

* 2 sessions including clinical assessments including questionnaires, brain activity assessment (with EEG), and back muscle activity assessment (with EMG) * 9 interventional sessions of active physiotherapy combined with active or sham tDCS during 3 weeks (3 per week).

Investigators will compare active tDCS with sham tDCS (non active) to evaluate if active tDCS is more effective than sham tDCS.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Chronic Low Back Pain

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Previous studies showed that transcranial Direct Current Stimulation (tDCS) targeting specific brain areas may offer novel treatment options in patients with chronic pain, in particular in chronic lower back pain (CLBP). Numerous tDCS trials have shown no evidence of moderate or severe adverse effects, highlighting tDCS as a safe, adequate tolerability and acceptability medical device.

However, several major limits remain before the investigators can start to design larger scale trials and more widespread clinical applications: the lack of knowledge on which brain region to target and about how neural activity is influenced by tDCS in this specific patient's population.

In consequence, the investigators do not know which setup of tDCS they can propose to CLBP patients. For instance, if the investigators manipulate brain interactions at the "wrong" tDCS setting, this may result in limited or no improvement of clinical deficits. Most existing randomized controlled trials (RCT) on tDCS treatment indeed show highly mixed effects which are likely due to incomplete understanding of tDCS-induced changes in brain and behavior. In addition, the majority of RCT have applied tDCS over the primary motor cortex (M1). Furthermore, the targeting of this brain region has recently been questioned and the dorsolateral prefrontal cortex (DLPFC) have been suggested as a valuable alternative. Knowing the mechanisms of action of tDCS based on the new rationale (i.e., tDCS targeting DLPFC) would allow us to define setup which are more likely to succeed.

The primary objective of this study is to investigate the effects of repeated sessions of tDCS combined with active physiotherapy on the multidimensional impact of pain at the end of the intervention compared to sham tDCS with active physiotherapy.

The secondary objectives are to compare the effects of these interventions on fear of movement, psycho-emotional state, function, functional connectivity of the left dorsolateral prefrontal cortex (DLPFC) and erector spinae activity.

The investigators hypothesise that tDCS combined with active physiotherapy will have a greater effect at the end of the intervention and at 3 and 6 months follow-up on all outcomes compared to sham tDCS combined with active physiotherapy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ability to give informed consent,
  • ability to follow protocol instructions,
  • diagnosis of Non Specific Chronic Low Back Pain ≥12 weeks,
  • low back pain with or without radiation to the knee,
  • average pain of the previous week ≥ 3 on the VAS (Visual Analogue Scale).
  • have sufficient cognitive ability to fill in the various questionnaires (Level B2 French),

Exclusion criteria

  • herniectomy within the last 6 months,
  • lumbar spinal surgery with material (e.g. prosthesis, spondylodesis),
  • sensory or motor deficit of a lower limb,
  • radiant pain in the lower limb beyond the knee,
  • neuropathic pain (according to the dn4 questionnaire),
  • diagnosis of an inflammatory rheumatic disease (e.g. rheumatoid arthritis, spondyloarthropathy),
  • diagnosis of a chronic generalized pain syndromee of fibromyalgia,
  • pregnancy,
  • presence of neurological or neuropsychiatric disorders,
  • have epilepsy or a recent or severe head injury,
  • metal implant in the skull (excluding fillings),
  • presence of a pacemaker,
  • unhealed wound or skin disease on the skull (electrode contact area)

Treatment and study plan

Anodal tDCS combined with active physiotherapy

Device

anodal tDCS over prefrontal cortex combined with active physiotherapy

Other names: transcranial Direct Current Stimulation, Soterix Medical mini-CT

Sham anodal tDCS combined with active physiotherapy

Device

Sham anodal tDCS over prefrontal cortex combined with active physiotherapy

Other names: Soterix Medical mini-CT

Primary outcomes

  1. Core Outcome Measures Index (COMI)

    Time frame: Change from baseline (T0) to immediately after the treatment period (T1)

    The Core Outcome Measures Index (COMI) comprises a short set of questions used to assess the impact of spinal disorders on multiple patient-orientated outcome domains. It is based on a set of individual items selected from established questionnaires and recommended for standardized use by an international group of experts in the field. It consists of seven items to assess the extent of the patient's back pain and leg pain, difficulties with functioning in everyday life, symptom-specific well-being, general quality of life, and social and work disability. A summary index score from 0 (best health status) to 10 (worst health status) can be computed by averaging the values of the five subscales.

    Scoring is done by completing one trial.

    Continuous measure, lower values indicate better outcome.

Secondary outcomes

  1. Core Outcome Measures Index (COMI)

    Time frame: Change from baseline (T0) to three months (T2) and six months after the inclusion (T3)

    The Core Outcome Measures Index (COMI) comprises a short set of questions used to assess the impact of spinal disorders on multiple patient-orientated outcome domains. It is based on a set of individual items selected from established questionnaires and recommended for standardized use by an international group of experts in the field. It consists of seven items to assess the extent of the patient's back pain and leg pain, difficulties with functioning in everyday life, symptom-specific well-being, general quality of life, and social and work disability. A summary index score from 0 (best health status) to 10 (worst health status) can be computed by averaging the values of the five subscales.

    Scoring is done by completing one trial.

    Continuous measure, lower values indicate better outcome.

  2. Numerical Pain Rating Scale

    Time frame: Change from baseline (T0) to immediately after the treatment period (T1) and three months (T2) and six months after the inclusion (T3)

    Numerical Pain Rating Scale assesses the level of pain on a range from 0 to 10, with 0 being no pain and 10 being the maximum possible pain. For a clinically relevant difference to exist, there has to be a difference between measurements of at least 2 points.

    This scale has been shown to have good levels of reliability for pain measurement.

    Scoring is done by completing one trial.

    Continuous measure, lower values indicate better outcome.

  3. Change from Oswestry Disability Index (ODI)

    Time frame: Change from baseline (T0) to immediately after the treatment period (T1) and three months (T2) and six months after the inclusion (T3)

    Oswestry Disability Index (ODI) will be used to analyze the quality of life in people with low back pain. This instrument contains in 10 items that assess the impact of low back pain on several functional activities. Values range from 0 to 5, the highest value indicating greater disability. The end result is the sum of all items.

    Scoring is done by completing one trial.

    Continuous measure, lower values indicate better outcome.

  4. Fear Avoidance Beliefs Questionnaire (FABQ)

    Time frame: Change from baseline (T0) to immediately after the treatment period (T1) and three months (T2) and six months after the inclusion (T3)

    Consists of 16 items a self-report questionnaire based on evaluation on the Fear-avoidance model.The maximum score is 96, that representing higher levels of fear-avoidance beliefs. The FABQ has two subscales: the work subscale (FABQw),and the physical activity subscale (FABQpa).

    Scoring is done by completing one trial.

    Continuous measure, lower values indicate better outcome

  5. Pain Catastrophizing as assessed by the Pain Catastrophizing Scale

    Time frame: Change from baseline (T0) to immediately after the treatment period (T1) and three months (T2) and six months after the inclusion (T3)

    The Pain Catastrophizing Scale (PCS) is a 13 item survey assessing catastrophizing in context to pain. There are 13 items with 5-pt Likert responses.

    There are several subscales. Scoring Procedure: The PCS total score is computed by summing responses to all 13 items (0-52).

    Subscales:

    Rumination: Sum of items 8, 9, 10, 11 (0-16). Magnification: Sum of items 6, 7, 13 (0-12). Helplessness: Sum of items 1, 2, 3, 4, 5, 12 (0-24).

    Scoring is done by completing one trial.

    Continuous measure, lower values indicate better outcome.

  6. Hospital Anxiety Depression Scale (HADS)

    Time frame: Change from baseline (T0) to immediately after the treatment period (T1) and three months (T2) and six months after the inclusion (T3)

    A questionnaire which has also been validated and translated into French. This scale has 14 items, 7 for anxiety subscale and 7 for depression. For each item there is a score of 0 to 3, with a total of 21 points for the scale.

    Scoring is done by completing one trial.

    Continuous measure, lower values indicate better outcome.

  7. Flexion Relaxation Ratio (FRR) on erector spinae

    Time frame: Change from baseline (T0) to immediately after the treatment period (T1)

    Flexion-relaxation ratio is calculated by dividing muscle activity (sEMG) during trunk flexion by muscle activity during full-flexed position. sEMG of lumbar paraspinal muscles is recorder through surface electromyogramm (sEMG) during every trials of each session.

    Scoring is done by completing three trials and calculating the average of the three trials to calculate the Flexion Relaxation Ratio (FRR).

  8. Functional connectivity from Electroencephalogram (EEG) recordings

    Time frame: Change from baseline (T0) to immediately after the treatment period (T1)

    Resting state Electroencephalogram (EEG) functional connectivity (FC) analysis will be calculated.The absolute imaginary component of coherence between Dorso Lateral Prefrontal Cortex (DLPFC) (left and right) and the rest of the brain will be subsequently calculated as index of functional connectivity.

    Continuous measure, higher values indicate better outcome.

Study contacts

Contact information is provided by the study sponsor or research team.

Stéphane Armand, Pr

CONTACT

[email protected]

+41 22 372 78 23

Thomas Pourchet, PT, MSc

CONTACT

[email protected]

+41 22 558 66 83

Sponsors and collaborators

Lead sponsor

Stephane ARMAND

Other

Collaborators

  • La Tour Hospital
  • School of Health Sciences Geneva

Registry information

Official study title

Innovative Non-invasive Brain Stimulation in the Rehabilitation of Patients With Chronic Low Back Pain

Acronym: STOP-CLBP

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Mar 7, 2023
Registry last updated
Dec 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.